New center will use cutting-edge AI to accelerate the creation of life-saving medicines AI Small Molecule Drug Discovery ...

The hiring freeze at the University of Washington threatens the research pipeline surging in the lab of Nobel Prize winner ...

Researchers found a protein that's essential for an enterovirus to enter human cells. Although not the infamous example—that ...

The technology, which in the past had been limited by size and cost, provides targeted doses of radiation to tumors, ...

The National Technical Honor Society (NTHS) of the Career Center recently held induction of new members for students selected ...

The 43rd Barcelona BioMed Conference showcased how AI is revolutionizing drug discovery, from generative compound design to ...

The Icahn School of Medicine at Mount Sinai has launched the AI Small Molecule Drug Discovery Center, a bold endeavor that harnesses artificial intelligence (AI) to revolutionize drug development.

The study results demonstrate the ability to improve the sense of smell with noninvasive devices in different types of users.

A powerful new software platform is set to transform biomedical research by allowing scientists to conduct complex and customized data analyses without advanced programming skills. The web-based ...

A tower crane has been installed for construction of the Wichita Biomedical Campus in downtown, marking the next significant ...

Taking advantage of a unique public health policy in the UK, a new study has found that receiving the shingles vaccine ...

Hematologist-oncologist Mateo Mejia Saldarriaga, MD, combines clinical care with research aimed at helping patients with ...